Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone bio to Participate in Upcoming Investor and Scientific Conferences

February 21, 2024

Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial

February 12, 2024

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 8, 2024

Gritstone bio to Participate in Upcoming Investor Conference

January 17, 2024

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 10, 2024

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 7, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

November 20, 2023

Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

November 8, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 7, 2023

Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine

October 11, 2023

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

© 2024 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Cookie Policy
Contact

socials

Top